KRYSTAL 12
KRYSTAL-12: Phase III Trial of Adagrasib vs Docetaxel in Previously Treated Advanced KRASG12C- Mutated NSCLC

Released: June 04, 2024

Expiration: June 03, 2025

Activity

Progress
1
Course Completed